$MRK Company News Don’t look for pricey hepatitis

New Post Public Reply Private Reply Replies (0) Message Board

Jan 16, 2015 at 12:55 PM

$MRK Company News

Don’t look for pricey hepatitis drugs to come down 2:32 p.m. Jan. 13, 2015 - Russ Britt
Three investments to own and three to 6:00 a.m. Jan. 13, 2015 - Howard Gold
Bristol-Myers Squibb jumps on Opdivo cancer drug test 8:17 a.m. Jan. 12, 2015 - Angela Chen
Here are the best-performing stocks so far in 2015 11:47 a.m. Jan. 9, 2015 - Philip van Doorn
Ebola vaccines ready for West Africa tests: WHO 11:11 a.m. Jan. 9, 2015 - MarketWatch.com
Health-care sector taking a broad beating as pricing fears grow 2:39 p.m. Dec. 23, 2014 - Tomi Kilgore
FDA approves Bristol-Myers’s skin cancer treatment Opdivo 6:09 p.m. Dec. 22, 2014 - Ron Winslow
Nike slips after hours as orders fail to impress 6:38 p.m. Dec. 18, 2014 - MarketWatch
Merck acquires OncoEthix for up to $375 million 8:41 a.m. Dec. 18, 2014 - Angela Chen
From China to the U.S., a surreal week in business news 9:28 a.m. Dec. 12, 2014 - Marek Fuchs
Human trial of experimental Merck Ebola vaccine is suspended 2:17 p.m. Dec. 11, 2014 - Jeanne Whalen
Restoration Hardware shares jump on earnings beat 6:46 p.m. Dec. 10, 2014 - MarketWatch
Merck drug shrank tumors in some breast cancer patients in trial 8:57 a.m. Dec. 10, 2014 - Peter Loftus
Here are today’s biggest S&P 500 losers ... and five winners 12:51 p.m. Dec. 9, 2014 - Philip van Doorn
H&R Block shares fall on quarterly miss 6:41 p.m. Dec. 8, 2014 - Sue Chang
The S&P 500 recorded its biggest drop in nearly 7 weeks 4:33 p.m. Dec. 8, 2014 - Sara Sjolin
Russell 2000 rattles cage on major resistance 11:15 a.m. Dec. 8, 2014 - Michael Ashbaugh
Dow 18,000 beckons, but a bottom in oil prices does not 7:42 a.m. Dec. 8, 2014 - Shawn Langlois
Newscast: Oil prices plunge 7:38 a.m. Dec. 8, 2014 - MarketWatch
Merck to buy Cubist Pharmaceuticals for $8.4 billion 7:26 a.m. Dec. 8, 2014 - Peter Loftus

Dow 30 Stock Roundup: JPM Results Disappoint, Microsoft Launches Affordable Handsets - Analyst Blog 9:19 a.m. Today - Zacks.com
Bristol-Myers' Opdivo - The New Cash Cow 9:08 a.m. Today - Seeking Alpha
How To Weight And Rebalance Your Dividend Growth Stocks 1:20 p.m. Jan. 15, 2015 - Seeking Alpha
Agilent Arm/Cell Signaling Tie for Companion Diagnostics - Analyst Blog 12:30 p.m. Jan. 15, 2015 - Zacks.com
Fast Money Halftime Report Final Trade From January 14 5:26 a.m. Jan. 15, 2015 - benzinga.com
Dogs Of The Dow: 2014 Year-End Review And Lineup For 2015 5:50 p.m. Jan. 14, 2015 - Seeking Alpha
Eli Lilly Inks Oncology Deals with Merck, Bristol-Myers - Analyst Blog 5:35 p.m. Jan. 14, 2015 - Zacks.com
Look for Value and Don’t Ignore Long-Term Trends Amid Rising Volatility 3:15 p.m. Jan. 14, 2015 - TheStreet.com
Dow Jones (DJIA) Today: Merck (MRK) Leads The Day Higher, JPMorgan Chase (JPM) Lags 1:30 p.m. Jan. 14, 2015 - TheStreet.com
Express Scripts is Biotech's Grinch 9:13 a.m. Jan. 14, 2015 - Seeking Alpha
Merck Speeds Up Lung Cancer, HCV Drugs; Filings in 1H15 - Analyst Blog 5:10 p.m. Jan. 13, 2015 - Zacks.com
Top Cybersecurity Stock Qualys Gets Support 4:42 p.m. Jan. 13, 2015 - Investors Business Daily
Bristol’s Lung Cancer Drug Aces Trial, Cheers Bulls 10:58 a.m. Jan. 13, 2015 - Barrons.com
Lilly to Collaborate on Cancer Drug Trials 8:52 a.m. Jan. 13, 2015 - The Wall Street Journal Interactive Edition
Lilly and Merck team up in cancer trials 8:44 a.m. Jan. 13, 2015 - Seeking Alpha
Agenus Soars on Immuno-Oncology Agreement with Incyte - Analyst Blog 6:45 p.m. Jan. 12, 2015 - Zacks.com
Bristol-Myers Hits 14-Year High On Cancer Drug Trial 1:25 p.m. Jan. 12, 2015 - Investors Business Daily
I'm Expecting Some Very Positive News Flow From Gilead 11:55 a.m. Jan. 12, 2015 - Seeking Alpha
5 Biotech Stocks With Explosive Drug Pipelines 8:01 a.m. Jan. 12, 2015 - InvestorPlace.com
Merck & Co., Inc. (MRK): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Jan. 12, 2015 - Zacks.com

Vaccine Manufacturing Technology and Services: World Market Forecast 2014-2024 10:36 a.m. Jan. 15, 2015 - PR Newswire - PRF
Insider Trading Alerts for Google, Oasis Petroleum, Best Buy, Twitter, Merck, and First Niagara Financial Group 8:45 a.m. Jan. 15, 2015 - PR Newswire - PRF
Global Ankylosing Spondylitis Market 2015-2019 4:16 p.m. Jan. 14, 2015 - PR Newswire - PRF
SynteractHCR Expands Senior Leadership to Oversee Growth of International Projects 10:00 a.m. Jan. 14, 2015 - BusinessWire - BZX
Practice Fusion Announces Positive Results of Population Health Vaccine Initiative Conducted in Collaboration with Merck 8:30 a.m. Jan. 14, 2015 - PR Newswire - PRF
Vista Partners Initiates Coverage on OncoSec Medical (Ticker: ONCS); Price Target $1.20 9:02 a.m. Jan. 13, 2015 - Marketwired
Lilly, Merck Enter Collaboration Agreement to Research Immuno-Oncology Combination Regimens in Multiple Types of Cancer 8:01 a.m. Jan. 13, 2015 - BusinessWire - BZX
Moderna Announces License and Collaboration Agreement with Merck to Develop Messenger RNA-based Antiviral Vaccines and Passive Immunity Therapies 8:00 a.m. Jan. 13, 2015 - PR Newswire - PRF
Neviah Genomics Achieves Key Development Milestone for PropheTox™ Bioassay for Early Prediction of Drug-Induced Liver Toxicity and Secures Additional Financing 7:00 a.m. Jan. 12, 2015 - BusinessWire - BZX
Adimab Announces New Partnerships with Acceleron, Oncothyreon, Surface Oncology and Potenza 9:45 a.m. Jan. 9, 2015 - BusinessWire - BZX
Beverage Industry Exec Ken Sadowsky Joins Theocorp Advisory Board 8:30 a.m. Jan. 9, 2015 - PR Newswire - PRF
Merck to Present at the 33rd Annual J.P. Morgan Healthcare Conference 8:00 a.m. Jan. 9, 2015 - BusinessWire - BZX
Protagen AG Appoints Bernhard Kirschbaum as New Board Member 10:00 a.m. Jan. 8, 2015 - BusinessWire - BZX
Jounce Therapeutics Appoints Deborah Law, D.Phil., to Chief Scientific Officer 9:01 a.m. Jan. 8, 2015 - BusinessWire - BZX
Global Needle-free Drug Delivery Technologies market 2015-2019 2:58 p.m. Jan. 7, 2015 - PR Newswire - PRF
Global Psoriasis Therapeutics Market 2015-2019 2:12 p.m. Jan. 7, 2015 - PR Newswire - PRF
Biotechs to Follow in 2015 off Fresh Insider Moves 10:00 a.m. Jan. 6, 2015 - ACCESSWIRE
HMR Weight Management Services Named No. 2 Best Weight-Loss Diet in U.S. News & World Report's Best Diets of 2015 9:15 a.m. Jan. 6, 2015 - PR Newswire - PRF
Scaling New Heights: Complimentary Research on Stereotaxis, Kite Pharma, ISIS Pharma, Merck and General Motors 8:50 a.m. Jan. 6, 2015 - PR Newswire - PRF
Theralase Anti-Cancer Technology Picks Up Steam 7:00 a.m. Jan. 6, 2015 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sportradar and DATA.BET: Expanding Esports Odds Offering

A Shift in the Esports Betting Landscape Well, it looks like we’ve hit another significant milestone in the esports betting universe. Sportradar, the sports tech giant known for pushing boundaries, has forged an intriguing alliance with DATA.BET, a sportsbook hotshot hailing from Cyprus. We're talking about a deal that’s set to shake up the esports betting scene with...

AI Deception Challenges the Confidence of Fraud Defenses

Fraud Week Spotlights AI Deception Alright, here's the rub: we're in Fraud Week 2026, and boy, is AI shaking the foundations of yesterday's fraud defenses! With all this AI talk, you would expect systems to be near invincible by now. But reality? A different beast altogether. AI has this knack of tripling up the complexity while pretending to solve it, making traditional...

Choosing Dance Styles: Tips from Expert Instructors

Navigating the Dance Style Maze Picking a dance style is no joke, especially when every option seems to spin its own tale. It ain't just about twirling to your favorite rhythm. There's a whole spectrum of styles, from graceful ballet to punchy hip-hop, each with its ticklish quirks and temptations. Sandy Young and Jenna Engen, dance experts from Young Dance Academy Inc....

Dyania, NVIDIA Team Up: AI Transforming Patient Care

Revving up efficiency in healthcare usually sounds like pie-in-the-sky talk, but every now and again, an innovation comes along that really stirs the pot. Enter Dyania Health's Synapsis AI, a clinical reasoning AI, teaming with NVIDIA's robust computing infrastructure. They're setting out to make sense of massive amounts of patient data, securely tucked behind a...

Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Aluminum Fluoride Market to Hit $3.3B by 2031

By Ryan Hughes Updated Nov 13, 2026 Category News Views 124

Eye on the Aluminum Fluoride Surge Cracking open the numbers, the aluminum fluoride market is projected to swell from $2.48 billion in 2026 to a hefty $3.30 billion by 2031, trucking along at a CAGR of 5.9%. That's no small potatoes in the world of industrial materials. Scratch the surface, and you’ll see what's fueling this climb—think of it as a bellwether for...

Classys Rides Revenue Surge, Eyes China Growth

By Caleb Price Updated Nov 13, 2026 Category News Views 108

Strong Numbers, But There's More to Unpack Nine months into 2026, Classys Inc. ain't exactly putting up shabby numbers. They've rolled in with KRW 275.7 billion like it was a stroll in the park, marking a sturdy 13% jump from last year. Yet, with all this, their operating profit has taken a 9.4% spill. It's a mixed bag, folks, and Classys is gearing up for a massive...

Timken Maintains Robust Dividend Streak in 2026

Timken Keeps Dividend Train Rolling You want to talk consistency? Timken Company just declared its quarterly dividend like clockwork. As a stockholder, that might just be your morning coffee fix before anything else. Notably, Timken's been on the NYSE since 1922, having cranked out 418 consecutive dividend payouts. That's like your grandpa never missing a Sunday golf...

vVARDIS Readies for Big Day on NYSE—IPO Set to Shine

vVARDIS Stepping into the Spotlight of the NYSE Alright, folks, here's one that could make some waves. vVARDIS is gearing up for its NYSE debut, trading under the ticker VVVV. They're no small fry talking about 9.72 million shares priced at 18 bucks a pop. This isn't just any run-of-the-mill company; they claim to have the first peptide-containing formulation for early...

Duke Energy's Cooling Tips Amid Florida Cold Front

Weather Whiplash in Florida Prompts Energy Tips Florida's residents are in for a gust of chilly air as a cold front sweeps across the state, sending temperatures plummeting from the balmy 80s to brisk 30s and 40s in northern pockets. Central Florida ain't missing out on the chill either, expecting to dip a good dozen degrees below its usual seasonal warmth. Heads up,...